Join us for a live virtual event on Oct. 15 on the impact of COVID-19 on people with chronic health conditions and how biopharma can address changing needs.
COVID-19 concern among people with chronic conditions has returned to early pandemic levels, according to a new survey from Health Union.
For the third consecutive year, Health Union has been recognized by Inc. magazine’s annual Inc. 5000 list, which represents the most prestigious ranking of the nation’s fastest-growing private companies. Health Union ranked No. 1,379 overall.
Large portions of people living with heart failure lack awareness of progression stage and ejection fraction, according to survey data from Health Union.
More than six in 10 people living with lupus said they feel frustrated there aren’t more treatment options for lupus, according to a Health Union survey.
For the first time, Health Union has been recognized in Inc. Magazine’s Best Workplaces program to honor exceptional workplaces with vibrant cultures.
Health Union, included in the healthcare industry category, ranked second on Forbes’ Best Startup Employers based in Philadelphia in 2020.
Despite the positive impact of treatments that lead to viral suppression, people living with HIV face various stigmas that negatively impact their lives.
Survey finds positive HCP relationships, negative quality of life for chronic migraine patients who currently use vs. never used CGRP therapies.
A Cystic Fibrosis survey finds patients who have never used a CFTR modulator are more likely to say CF negatively impacts their overall quality of life.